← Back to all trials
Recruiting
NCT07551986
Building Cognitive Resilience to Vaccine Misinformation Using AI in Europe
Conditions: Healthy
Sex: All
Ages: 20 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 5000
Sponsor: London School of Hygiene and Tropical Medicine
Location: London School of Hygiene and Tropical Medicine London
Summary
This multi-country trial evaluates an AI chatbot designed to counter cognitive biases and inoculate parents against vaccine misinformation, embedded within a large survey across five European countries (n=5,000). Scaled from a 2026 single-country study, outcomes compare behavioural and attitudinal responses against standard-of-care materials (e.g., UNICEF infographics) to identify effective, scalable misinformation interventions.
Eligibility Criteria
Inclusion Criteria:
* Parents or caregivers with children under 18 years old in the five target countries (UK, Netherlands, Croatia, Latvia, and Slovakia); and
* Those who have regular access to a digital device and the internet
Exclusion Criteria:
* Participants who do not meet the inclusion criteria.
Source: ClinicalTrials.gov (NCT07551986). StuddyBuddy aggregates publicly available trial information.